Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-06-13 5:31 pm Purchase |
2025-06-06 | 13G | Venus Concept Inc. VERO |
Mitchell P. Kopin | 120,474 4.990% |
82,698 (+218.92%) |
Filing History |
| 2025-06-13 5:31 pm Purchase |
2025-06-09 | 13G | Nuwellis, Inc. NUWE |
Mitchell P. Kopin | 251,087 4.990% |
251,087 (New Position) |
Filing History |
| 2025-06-13 5:30 pm Purchase |
2025-06-11 | 13G | Draganfly Inc. DPRO |
Mitchell P. Kopin | 670,154 4.990% |
670,154 (New Position) |
Filing History |
| 2025-05-30 5:12 pm Purchase |
2025-05-28 | 13G | Imunon, Inc. IMNN |
Mitchell P. Kopin | 1,111,112 5.500% |
1,111,112 (New Position) |
Filing History |
| 2025-05-27 5:30 pm Purchase |
2025-05-20 | 13G | Jaguar Health, Inc. JAGX |
Mitchell P. Kopin | 65,002 4.990% |
65,002 (New Position) |
Filing History |
| 2025-05-23 4:18 pm Purchase |
2025-05-19 | 13G | Cemtrex, Inc. CETX |
Mitchell P. Kopin | 198,066 9.990% |
198,066 (New Position) |
Filing History |
| 2025-05-23 4:17 pm Purchase |
2025-05-19 | 13G | Sunshine Biopharma, Inc. SBFM |
Mitchell P. Kopin | 505,653 9.990% |
505,653 (New Position) |
Filing History |
| 2025-05-21 5:19 pm Purchase |
2025-05-15 | 13G | Silo Pharma, Inc. SILO |
Mitchell P. Kopin | 784,630 9.990% |
549,103 (+233.14%) |
Filing History |
| 2025-05-12 4:08 pm Purchase |
2025-05-06 | 13G | Pasithea Therapeutics Corp. KTTA |
Mitchell P. Kopin | 317,863 4.990% |
317,863 (New Position) |
Filing History |
| 2025-05-09 4:04 pm Purchase |
2025-03-31 | 13G | NAYA Biosciences, Inc. Common Stock IVF |
Mitchell P. Kopin | 34,981 4.990% |
34,981 (New Position) |
Filing History |
| 2025-05-09 4:04 pm Sale |
2025-03-31 | 13G | Dermata Therapeutics, Inc. DRMA |
Mitchell P. Kopin | 23,340 0.400% |
-239,128 (-91.11%) |
Filing History |
| 2025-05-09 4:03 pm Purchase |
2025-03-31 | 13G | Mustang Bio, Inc. MBIO |
Mitchell P. Kopin | 236,452 8.800% |
49,900 (+26.75%) |
Filing History |
| 2025-05-09 4:02 pm Purchase |
2025-03-31 | 13G | Color Star Technology Co., Ltd. ADD |
Mitchell P. Kopin | 2,668,704 9.990% |
2,164,216 (+428.99%) |
Filing History |
| 2025-05-09 4:02 pm Sale |
2025-03-31 | 13G | Microbot Medical Inc. MBOT |
Mitchell P. Kopin | 2,349,488 6.300% |
-322,596 (-12.07%) |
Filing History |
| 2025-04-25 4:07 pm Unchanged |
2025-04-21 | 13G | Aptevo Therapeutics Inc. APVO |
Mitchell P. Kopin | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2025-04-17 4:04 pm Purchase |
2025-04-11 | 13G | Innovative Eyewear, Inc. LUCY |
Mitchell P. Kopin | 333,071 9.990% |
206,998 (+164.19%) |
Filing History |
| 2025-04-15 5:08 pm Purchase |
2025-04-09 | 13G | Venus Concept Inc. VERO |
Mitchell P. Kopin | 37,776 2.600% |
37,776 (New Position) |
Filing History |
| 2025-04-14 5:32 pm Purchase |
2025-04-08 | 13G | American Rebel Holdings, Inc. AREB |
Mitchell P. Kopin | 140,339 9.990% |
140,339 (New Position) |
Filing History |
| 2025-04-09 5:31 pm Unchanged |
2025-04-03 | 13G | Aptevo Therapeutics Inc. APVO |
Mitchell P. Kopin | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2025-04-07 4:17 pm Purchase |
2025-04-01 | 13G | GRI Bio, Inc. GRI |
Mitchell P. Kopin | 40,261 4.990% |
40,261 (New Position) |
Filing History |